» Articles » PMID: 17384639

Proteome Analysis of Soluble Nuclear Proteins Reveals That HMGB1/2 Suppress Genotoxic Stress in Polyglutamine Diseases

Overview
Journal Nat Cell Biol
Specialty Cell Biology
Date 2007 Mar 27
PMID 17384639
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear dysfunction is a key feature of the pathology of polyglutamine (polyQ) diseases. It has been suggested that mutant polyQ proteins impair functions of nuclear factors by interacting with them directly in the nucleus. However, a systematic analysis of quantitative changes in soluble nuclear proteins in neurons expressing mutant polyQ proteins has not been performed. Here, we perform a proteome analysis of soluble nuclear proteins prepared from neurons expressing huntingtin (Htt) or ataxin-1 (AT1) protein, and show that mutant AT1 and Htt similarly reduce the concentration of soluble high mobility group B1/2 (HMGB1/2) proteins. Immunoprecipitation and pulldown assays indicate that HMGBs interact with mutant AT1 and Htt. Immunohistochemistry showed that these proteins were reduced in the nuclear region outside of inclusion bodies in affected neurons. Compensatory expression of HMGBs ameliorated polyQ-induced pathology in primary neurons and in Drosophila polyQ models. Furthermore, HMGBs repressed genotoxic stress signals induced by mutant Htt or transcriptional repression. Thus, HMGBs may be critical regulators of polyQ disease pathology and could be targets for therapy development.

Citing Articles

PQBP3 prevents senescence by suppressing PSME3-mediated proteasomal Lamin B1 degradation.

Yoshioka Y, Huang Y, Jin X, Ngo K, Kumaki T, Jin M EMBO J. 2024; 43(18):3968-3999.

PMID: 39103492 PMC: 11405525. DOI: 10.1038/s44318-024-00192-4.


The Role of NRF2 in Trinucleotide Repeat Expansion Disorders.

Chang K, Chen C Antioxidants (Basel). 2024; 13(6).

PMID: 38929088 PMC: 11200942. DOI: 10.3390/antiox13060649.


Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage.

Homma H, Yoshioka Y, Fujita K, Shirai S, Hama Y, Komano H Commun Biol. 2024; 7(1):413.

PMID: 38594382 PMC: 11003991. DOI: 10.1038/s42003-024-06066-z.


Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics.

Kaur J, Singh H, Naqvi S Mol Neurobiol. 2023; 60(7):3600-3616.

PMID: 36859688 DOI: 10.1007/s12035-023-03289-9.


Transcription factor EB-mediated mesenchymal stem cell therapy induces autophagy and alleviates spinocerebellar ataxia type 3 defects in neuronal cells model.

Han X, Habimana J, Li A, Huang R, Mukama O, Deng W Cell Death Dis. 2022; 13(7):622.

PMID: 35851059 PMC: 9293975. DOI: 10.1038/s41419-022-05085-0.